Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Maxim Group Initiates Coverage On Genelux with Buy Rating, Announces Price Target of $40

Author: Benzinga Newsdesk | September 12, 2023 09:49am

Maxim Group analyst Jason McCarthy initiates coverage on Genelux (NASDAQ:GNLX) with a Buy rating and announces Price Target of $40.

Posted In: GNLX